83
49
Growth Score
-7 pts
Heat Score
-31 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
503017
Nova In Silico offers AI-driven clinical trial simulations to optimize drug development.
- François Boissel: Founder & AmbassadorPast Role: Novadiscovery, CEO & Co-Founder
About the Company
Nova In Silico specializes in AI-driven in silico clinical trial simulations. Their platform, jinkō, is designed to predict drug efficacy and optimize clinical trial development. The company integrates expertise from various fields including biology, medicine, clinical pharmacology, applied mathematics, data science, and artificial intelligence to
enhance the drug discovery process. By leveraging mechanistic modeling and AI, Nova In Silico aims to transform the way clinical trials are conducted, potentially reducing time and costs associated with drug development.
